VOYAGER THERAPEUTICS INC. - COMMON STOCK

3.4700

25-April-25 16:45:00

15 minutes delayed

Stocks

-0.0600

-1.70%

Today's range

3.4150 - 3.5787

ISIN

N/A

Source

NASDAQ

Voyager Therapeutics’ Novel Capsids Demonstrate Robust Delivery Across the Blood Brain Barrier, Widespread CNS Transduction in Non-Human Primates

11 May 2021 07:30:00 By Nasdaq GlobeNewswire
Voyager Therapeutics Announces First Quarter 2021 Financial Results and Corporate Updates

10 May 2021 07:30:00 By Nasdaq GlobeNewswire
Voyager Therapeutics Announces Upcoming Data Presentations at the American Society of Gene and Cell Therapy Virtual 2021 Annual Meeting

28 Apr 2021 08:00:02 By Nasdaq GlobeNewswire
Voyager Therapeutics Receives FDA Clearance of IND Application for Gene Therapy Candidate VY-HTT01 for Treatment of Huntington’s Disease

26 Apr 2021 08:00:01 By Nasdaq GlobeNewswire
Voyager Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Corporate Updates

25 Feb 2021 16:01:01 By Nasdaq GlobeNewswire
Voyager Therapeutics to Report Fourth Quarter and Full Year 2020 Financial Results and Participate in Upcoming Investor Conference

18 Feb 2021 16:01:00 By Nasdaq GlobeNewswire
Voyager Therapeutics Provides Update on NBIb-1817 (VY-AADC) Gene Therapy Program

02 Feb 2021 16:01:00 By Nasdaq GlobeNewswire
Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

11 Jan 2021 16:03:16 By Nasdaq GlobeNewswire

<<
<
3
4
5
6
7
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.